Patient characteristics
| Characteristics . | All patients (n = 26) . | |
|---|---|---|
| Number . | Percentage . | |
| Age, y | ||
| Median | 57 | |
| Range | 27-70 | |
| Sex | ||
| Male | 16 | 62 |
| Female | 10 | 38 |
| No. of involved organs | ||
| Median | 2 | |
| Range | 1-6 | |
| Heart | 15 | 58 |
| Kidney | 15 | 58 |
| Liver | 7 | 27 |
| Peripheral nerve | 3 | 12 |
| Patients with high-risk disease | 10 | 38 |
| Involved serum FLC, mg/L | ||
| Median | 187 | |
| Range | 18-9650 | |
| NT-pro BNP, ng/L | ||
| Median | 1140 | |
| Range | 194-21 091 | |
| Missing | 11 | |
| > 332 ng/L12 | 12/15 | 80 |
| Characteristics . | All patients (n = 26) . | |
|---|---|---|
| Number . | Percentage . | |
| Age, y | ||
| Median | 57 | |
| Range | 27-70 | |
| Sex | ||
| Male | 16 | 62 |
| Female | 10 | 38 |
| No. of involved organs | ||
| Median | 2 | |
| Range | 1-6 | |
| Heart | 15 | 58 |
| Kidney | 15 | 58 |
| Liver | 7 | 27 |
| Peripheral nerve | 3 | 12 |
| Patients with high-risk disease | 10 | 38 |
| Involved serum FLC, mg/L | ||
| Median | 187 | |
| Range | 18-9650 | |
| NT-pro BNP, ng/L | ||
| Median | 1140 | |
| Range | 194-21 091 | |
| Missing | 11 | |
| > 332 ng/L12 | 12/15 | 80 |
NT-pro BNP indicates N-terminal pro brain natriuretic peptide.